3B Pharmaceuticals has become a leading player in the discovery and development of innovative radiopharmaceutical cancer medicines and diagnostics. Building on its core expertise in peptide drug discovery 3BP has developed a broad product pipeline of which several programs…
Genmab uses ActivityBase XE to analyze results from its discovery activities, accelerating research into cancer, inflammatory conditions and infectious diseases. The challenge Using unique antibody technology to target specific antigens involved in the pathology of disease, Genmab…
Leading French biotech uses IDBS’ ActivityBase to optimize HTS and HCS. Inventiva has seen a tenfold decrease in the time it takes to complete analysis work. A spin-off of Abbott, Inventiva is a French biotech company specializing in running and…
